Ultrastructural and cellular basis for the development of abnormal myocardial mechanics during the transition from hypertension to heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 306, Issue 1, 2014, Pages

  Shah, Sanjiv J ^a   Aistrup, Gary L ^a   Gupta, Deepak K ^a   O'Toole, Matthew J ^a   Nahhas, Amanda F ^a   Schuster, Daniel ^a   Chirayil, Nimi ^a   Bassi, Nikhil ^a   Ramakrishna, Satvik ^a   Beussink, Lauren ^a   Misener, Sol ^a   Kane, Bonnie ^a   Wang, David ^a   Randolph, Blake ^a   Ito, Aiko ^a   Wu, Megan ^a   Akintilo, Lisa ^a   Mongkolrattanothai, Thitipong ^a   Reddy, Mahendra ^a   Kumar, Manvinder ^a   Arora, Rishi ^a   Ng, Jason ^a   Wasserstrom, J Andrew ^a   more..

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Calcium transients; Heart failure; Hypertension; T tubules; Ventricular mechanics

Indexed keywords

CALCIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; HEART FAILURE; HEART MUSCLE; HEART MUSCLE FIBROSIS; HYPERTENSION; MECHANICS; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC DYSFUNCTION; TISSUE DOPPLER IMAGING; TRANSVERSE TUBULAR SYSTEM;

EID: 84891528639     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00642.2013     Document Type: Article

References (43)

1. Ammar KA, Jacobsen SJ, Mahoney DW, Kors JA, Redfield MM, Burnett JC Jr, Rodeheffer RJ. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/ American Heart Association heart failure staging criteria in the community. Circulation 115: 1563-1570, 2007.
2. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B: 289-300, 1995.
3. Chen-Izu Y, Ward CW, StarkWJr, Banyasz T, Sumandea MP, Balke CW, Izu LT, Wehrens XH. Phosphorylation of RyR2 and shortening of RyR2 cluster spacing in spontaneously hypertensive rat with heart failure. Am J Physiol Heart Circ Physiol 293: H2409-H2417, 2007.
4. Chen B, Li Y, Jiang S, Xie YP, Guo A, Kutschke W, Zimmerman K, Weiss RM, Miller FJ, Anderson ME, Song LS.-Adrenergic receptor antagonists ameliorate myocyte T-tubule remodeling following myocardial infarction. FASEB J 26: 2531-2537, 2012.
5. 2+ overload causes mitochondrial-dependent apoptosis in ventricular myocytes. Circ Res 97: 1009-1017, 2005.
6. Delbridge LM, Connell PJ, Morgan TO, Harris PJ. Contractile function of cardiomyocytes from the spontaneously hypertensive rat. J Mol Cell Cardiol 28: 723-733, 1996.
7. Doggrell SA, Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res 39: 89-105, 1998.
8. Edvardsen T, Rosen BD, Pan L, Jerosch-Herold M, Lai S, Hundley WG, Sinha S, Kronmal RA, Bluemke DA, Lima JA. Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging-the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 151: 109-114, 2006.
9. Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, Nesser HJ, Khandheria B, Narula J, Sengupta PP. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr 23: 351-369, 2010.
10. Gomez AM, Guatimosim S, Dilly KW, Vassort G, Lederer WJ. Heart failure after myocardial infarction: altered excitation-contraction coupling. Circulation 104: 688-693, 2001.
11. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 276: 800-806, 1997.
12. Houser SR, Margulies KB, Murphy AM, Spinale FG, Francis GS, Prabhu SD, Rockman HA, Kass DA, Molkentin JD, Sussman MA, Koch W. Animal models of heart failure: a scientific statement from the American Heart Association. Circ Res 111: 131-150, 2012.
13. Ibrahim M, Gorelik J, Yacoub MH, Terracciano CM. The structure and function of cardiac t-tubules in health and disease. Proc Biol Sci 278: 2714-2723, 2011.
14. Izzo JL Jr, Gradman AH. Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure. Med Clin North Am 88: 1257-1271, 2004.
15. Jessup M, Brozena S. Heart failure. N Engl J Med 348: 2007-2018, 2003.
16. Kang SJ, Lim HS, Choi BJ, Choi SY, Hwang GS, Yoon MH, Tahk SJ, Shin JH. Longitudinal strain and torsion assessed by two-dimensional speckle tracking correlate with the serum level of tissue inhibitor of matrix metalloproteinase-1, a marker of myocardial fibrosis, in patients with hypertension. J Am Soc Echocardiogr 21: 907-911, 2008.
17. Kapur S, Aistrup GL, Sharma R, Kelly JE, Arora R, Zheng J, Veramasuneni M, Kadish AH, Balke CW, Wasserstrom JA. Early development of intracellular calcium cycling defects in intact hearts of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 299: H1843-H1853, 2010.
18. Kosmala W, Plaksej R, Strotmann JM, Weigel C, Herrmann S, Niemann M, Mende H, Stork S, Angermann CE, Wagner JA, Weidemann F. Progression of left ventricular functional abnormalities in hypertensive patients with heart failure: an ultrasonic two-dimensional speckle tracking study. J Am Soc Echocardiogr 21: 1309-1317, 2008.
19. Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE. Recommendations for blood pressure measurement in humans and experimental animals. Part 2: blood pressure measurement in experimental animals: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. Hypertension 45: 299-310, 2005.
20. Leggio M, Sgorbini L, Pugliese M, Mazza A, Bendini MG, Fera MS, Giovannini E, Leggio F. Systo-diastolic ventricular function in patients with hypertension: an echocardiographic tissue doppler imaging evaluation study. Int J Cardiovasc Imaging 23: 177-184, 2007.
21. 2+ release in human failing cardiomyocytes. Cardiovasc Res 62: 63-73, 2004.
22. 2+ release in murine cardiomyocytes following myocardial infarction. J Physiol 574: 519-533, 2006.
23. Lyon AR, MacLeod KT, Zhang Y, Garcia E, Kanda GK, Lab MJ, Korchev YE, Harding SE, Gorelik J. Loss of T-tubules and other changes to surface topography in ventricular myocytes from failing human and rat heart. Proc Natl Acad Sci USA 106: 6854-6859, 2009.
24. Lyon AR, Nikolaev VO, Miragoli M, Sikkel MB, Paur H, Benard L, Hulot JS, Kohlbrenner E, Hajjar RJ, Peters NS, Korchev YE, Macleod KT, Harding SE, Gorelik J. Plasticity of surface structures and 2-adrenergic receptor localization in failing ventricular cardiomyocytes during recovery from heart failure. Circ Heart Fail 5: 357-365, 2012.
25. Meethal SV, Potter KT, Redon D, Munoz-del-Rio A, Kamp TJ, Valdivia HH, Haworth RA. Structure-function relationships of Ca spark activity in normal and failing cardiac myocytes as revealed by flash photography. Cell Calcium 41: 123-134, 2007.
26. 2+-dependent transgenic model of cardiac hypertrophy: a role for protein kinase Cα. Circulation 103: 140-147, 2001.
27. 2+-and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Invest 117: 2431-2444, 2007.
28. Narayanan A, Aurigemma GP, Chinali M, Hill JC, Meyer TE, Tighe DA. Cardiac mechanics in mild hypertensive heart disease: a specklestrain imaging study. Circ Cardiovasc Imaging 2: 382-390, 2009.
29. Patten RD, Hall-Porter MR. Small animal models of heart failure: development of novel therapies, past and present. Circ Heart Fail 2: 138-144, 2009.
30. Peng Y, Popovic ZB, Sopko N, Drinko J, Zhang Z, Thomas JD, Penn MS. Speckle tracking echocardiography in the assessment of mouse models of cardiac dysfunction. Am J Physiol Heart Circ Physiol 297: H811-H820, 2009.
31. +]i handling in the failing human heart. Cardiovasc Res 57: 874-886, 2003.
32. Popovic ZB, Benejam C, Bian J, Mal N, Drinko J, Lee K, Forudi F, Reeg R, Greenberg NL, Thomas JD, Penn MS. Speckle-tracking echocardiography correctly identifies segmental left ventricular dysfunction induced by scarring in a rat model of myocardial infarction. Am J Physiol Heart Circ Physiol 292: H2809-H2816, 2007.
33. Popovic ZB, Kwon DH, Mishra M, Buakhamsri A, Greenberg NL, Thamilarasan M, Flamm SD, Thomas JD, Lever HM, Desai MY. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. J Am Soc Echocardiogr 21: 1299-1305, 2008.
34. Poulsen SH, Andersen NH, Ivarsen PI, Mogensen CE, Egeblad H. Doppler tissue imaging reveals systolic dysfunction in patients with hypertension and apparent "isolated" diastolic dysfunction. J Am Soc Echocardiogr 16: 724-731, 2003.
35. Rosen BD, Edvardsen T, Lai S, Castillo E, Pan L, Jerosch-Herold M, Sinha S, Kronmal R, Arnett D, Crouse JR, 3rd Heckbert SR, Bluemke DA, Lima JA. Left ventricular concentric remodeling is associated with decreased global and regional systolic function: the Multi-Ethnic Study of Atherosclerosis. Circulation 112: 984-991, 2005.
36. Rovner A, de las Fuentes L, Waggoner AD, Memon N, Chohan R, Davila-Roman VG. Characterization of left ventricular diastolic function in hypertension by use of Doppler tissue imaging and color M-mode techniques. J Am Soc Echocardiogr 19: 872-879, 2006.
37. Rysa J, Leskinen H, Ilves M, Ruskoaho H. Distinct upregulation of extracellular matrix genes in transition from hypertrophy to hypertensive heart failure. Hypertension 45: 927-933, 2005.
38. Saito M, Okayama H, Yoshii T, Higashi H, Morioka H, Hiasa G, Sumimoto T, Inaba S, Nishimura K, Inoue K, Ogimoto A, Shigematsu Y, Hamada M, Higaki J. Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 13: 617-623, 2012.
39. Song LS, Sobie EA, McCulle S, Lederer WJ, Balke CW, Cheng H. Orphaned ryanodine receptors in the failing heart. Proc Natl Acad Sci USA 103: 4305-4310, 2006.
40. Tsioufis C, Chatzis D, Dimitriadis K, Stougianos P, Kakavas A, Vlasseros I, Tousoulis D, Stefanadis C, Kallikazaros I. Left ventricular diastolic dysfunction is accompanied by increased aortic stiffness in the early stages of essential hypertension: a TDI approach. J Hypertens 23: 1745-1750, 2005.
41. Wasserstrom JA, Sharma R, Kapur S, Kelly JE, Kadish AH, Balke CW, Aistrup GL. Multiple defects in intracellular calcium cycling in whole failing rat heart. Circ Heart Fail 2: 223-232, 2009.
42. Wei S, Guo A, Chen B, Kutschke W, Xie YP, Zimmerman K, Weiss RM, Anderson ME, Cheng H, Song LS. T-tubule remodeling during transition from hypertrophy to heart failure. Circ Res 107: 520-531, 2010.
43. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 47: 76-84, 2006.